Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,516 results that match your search.22,516 results
  • Erik Wilbers, director of WIPO's Arbitration and Mediation Center, speaks to Managing IP about growing comfort with alternative dispute resolution (ADR) in IP and the role that ADR can play in FRAND disputes
  • Kim Dotcom attending an extradition hearing in New Zealand, Rick Ross failing in a trade mark suit over the phrase "everyday I'm shufflin", Segway suing the makers of Hovertrax, and Adidas claiming Skechers has infringed its trade mark were in the IP headlines in the past week
  • Citing concerns about 'stale' patents, the Federal Circuit has ruled, en banc, that laches is a statutory defence in the Patent Act and may be a defence to both legal and equitable remedies
  • EPO to donate €100k to refugee crisis, EU MEPs support extension of GI protection, tips offered at the Global Innovation Index launch, EC backs TRIPs exemption for least-developed countries, consultation on Mediation Directive and the Unitary Patent and UPC latest were in the IP headlines in Europe this week
  • An applicant for a trade mark based on acquired distinctiveness must prove that that mark alone (as opposed to any other mark present on the product) identifies the origin of the goods or services. So said the Court of Justice of the EU in a dispute between Nestlé and Cadbury over the shape of the Kit Kat bar
  • PTAB petition filing has recovered from a lull in July. The 177 petitions filed in September were up 44% on the previous month
  • The UK IPO is making progress with the IT system, draft Rules on the European Patent Litigation Certificate have been agreed, proposals for the Patent Mediation and Arbitration Centre rules are imminent, and Finland and Italy are preparing to ratify the UPC Agreement
  • Following the guidance from the Court of Appeal, Mr Justice Arnold has ruled that some of the claims of Warner-Lambert's second medical use patent for the drug pregabalin are invalid, and that Actavis has not infringed two claims directed to the use of pregabalin
  • James Nurton selects five highlights from the first 24 hours of this year’s MARQUES Annual Conference, spanning everything from neuroscience to survey evidence and Austria’s biggest brands